Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica

Non-alcoholic fatty liver disease (NAFDL) includes fatty liver or simple steatosis, characterized by lipid deposits in hepatocytes and more advanced stages such as steatohepatitis (NASH) and non-alcoholic cirrhosis. Physical inactivity, hypercaloric and unbalanced diet together with aging play a key...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lanuza,Fabian, Sapunar,Jorge, Hofmann,Edmundo
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2018
Materias:	Non-alcoholic Fatty Liver Disease Diet Exercise Pharmacology
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000800894
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872018000800894
record_format	dspace
spelling	oai:scielo:S0034-988720180008008942018-10-18Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólicaLanuza,FabianSapunar,JorgeHofmann,Edmundo Non-alcoholic Fatty Liver Disease Diet Exercise Pharmacology Non-alcoholic fatty liver disease (NAFDL) includes fatty liver or simple steatosis, characterized by lipid deposits in hepatocytes and more advanced stages such as steatohepatitis (NASH) and non-alcoholic cirrhosis. Physical inactivity, hypercaloric and unbalanced diet together with aging play a key role in the pathogenesis of NAFLD and are strongly associated with metabolic and physical activity continue to be major components in prevention and first-line treatment to attenuate or reverse NAFLD. Dietary patterns, their composition and weight reduction would be the most relevant nutritional aspects in NAFDL treatment. Physical exercise, moderate to intense, aerobic and resistance type contributes to weight loss, improves metabolic control and body composition. Pharmacological therapy can be useful in clinical circumstances that require it and needs a medical evaluation when there is no adherence and success in non-pharmacological interventions.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.8 20182018-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000800894es10.4067/s0034-98872018000800894
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Non-alcoholic Fatty Liver Disease Diet Exercise Pharmacology
spellingShingle	Non-alcoholic Fatty Liver Disease Diet Exercise Pharmacology Lanuza,Fabian Sapunar,Jorge Hofmann,Edmundo Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
description	Non-alcoholic fatty liver disease (NAFDL) includes fatty liver or simple steatosis, characterized by lipid deposits in hepatocytes and more advanced stages such as steatohepatitis (NASH) and non-alcoholic cirrhosis. Physical inactivity, hypercaloric and unbalanced diet together with aging play a key role in the pathogenesis of NAFLD and are strongly associated with metabolic and physical activity continue to be major components in prevention and first-line treatment to attenuate or reverse NAFLD. Dietary patterns, their composition and weight reduction would be the most relevant nutritional aspects in NAFDL treatment. Physical exercise, moderate to intense, aerobic and resistance type contributes to weight loss, improves metabolic control and body composition. Pharmacological therapy can be useful in clinical circumstances that require it and needs a medical evaluation when there is no adherence and success in non-pharmacological interventions.
author	Lanuza,Fabian Sapunar,Jorge Hofmann,Edmundo
author_facet	Lanuza,Fabian Sapunar,Jorge Hofmann,Edmundo
author_sort	Lanuza,Fabian
title	Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
title_short	Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
title_full	Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
title_fullStr	Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
title_full_unstemmed	Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
title_sort	análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
publisher	Sociedad Médica de Santiago
publishDate	2018
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000800894
work_keys_str_mv	AT lanuzafabian analisiscriticodeltratamientodelaenfermedadhepaticagrasanoalcoholica AT sapunarjorge analisiscriticodeltratamientodelaenfermedadhepaticagrasanoalcoholica AT hofmannedmundo analisiscriticodeltratamientodelaenfermedadhepaticagrasanoalcoholica
_version_	1718437019426750464

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica

Ejemplares similares